Portfolio

• Active
• Biopharmaceuticals
• Devices & Diagnostics
• IPO/Merger
• Full List

Print

Sensys Medical

Chandler, AZ

Sensys is developing a non-invasive blood glucose monitor that uses near infrared diffuse reflectance spectroscopy. Once cleared by the Food and Drug Administration, the technology will provide a painless method to collect data for proactive use in controlling diabetes.